Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Leon Ravin

Psychiatry Pittsburgh, PA Medical Doctor

NPI 1760417364 CMS profile 260941

3811 Ohara St, Pittsburgh, PA 15213

Open in the dashboard

General payments

$106,477

475 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Leon Ravin of Pittsburgh, PA is reported in the CMS Open Payments database as having received $106,477 across 475 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,772 29
2024 General $2,914 45
2023 General $12,984 80
2022 General $26,169 92
2021 General $10,312 55
2020 General $8,931 24
2019 General $43,395 150

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Leon Ravin
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Leon Ravin were reported at $1,772. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Leon Ravin Psychiatry median Middle half National median
2019 $43,395 $184 $59–$605 $163
2020 $8,931 $119 $36–$372 $114
2021 $10,312 $143 $43–$576 $132
2022 $26,169 $153 $50–$590 $149
2023 $12,984 $170 $56–$651 $160
2024 $2,914 $179 $57–$673 $164
2025 $1,772 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alkermes, Inc. $43,858 96 payments
  2. Janssen Pharmaceuticals, Inc $35,979 100 payments
  3. Otsuka Pharmaceutical Development & Commercialization, Inc. $10,204 16 payments
  4. BioXcel Therapeutics, Inc. $6,066 18 payments
  5. Otsuka America Pharmaceutical, Inc. $3,766 64 payments
  6. Neurocrine Biosciences, Inc. $2,250 60 payments
  7. Teva Pharmaceuticals USA, Inc. $1,150 18 payments
  8. ITI, Inc. $894 32 payments
  9. Sunovion Pharmaceuticals Inc. $742 27 payments
  10. Janssen Scientific Affairs, LLC $342 4 payments
  11. Other $1,226 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $82,350 39 payments
  2. Food and Beverage $13,779 386 payments
  3. Travel and Lodging $10,193 41 payments
  4. Education $156 9 payments
Products named General payments · program years 2019–2025
  1. ARISTADA Cns $43,417 89 payments
  2. ARISTADA Cns $43,417 89 payments
  3. ARISTADA Cns $43,181 78 payments
  4. ARISTADA Cns $43,181 78 payments
  5. ARISTADA INITIO $43,026 77 payments
  6. SPRAVATO $34,578 58 payments
  7. IGALMI $6,066 18 payments
  8. INVEGA SUSTENNA $2,096 59 payments
  9. ABILIFY MAINTENA $1,179 65 payments
  10. UZEDY $1,080 16 payments
  11. Other $7,634 243 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

475 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record